As the Wuhan coronavirus outbreak continues to spread, two Israeli companies are finalizing development of revolutionary antiviral reusable facemasks.
“Israel has technologies that can support controlling this epidemic,” says Liat Goldhammer-Steinberg, CTO of Sonovia in Ramat Gan.
More than 100 people are reported dead from complications of Wuhan coronavirus, dubbed 2019-nCoV.
The virus is spread by air and direct contact. The World Health Organization reports approximately 4,200 cases of infection since December 31. Most of the cases are in China. A few have been confirmed in 15 additional countries.
Because there is no vaccine or treatment for 2019-nCoV, personal protective equipment is an important way to combat the transmission of the virus and avoid a pandemic.
Disposable facemasks cannot block all pathogens and do not kill them. A used and discarded mask can even become a vector for disease as the pathogens multiply in its fibers.
That’s why washable, reusable masks with anti-pathogen properties could provide a potent prevention tool against the 2019-nCoV and other coronaviruses that have evolved into more severe illnesses, such as SARS and MERS.-- More...
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
As the Wuhan coronavirus outbreak continues to spread, two Israeli companies are finalizing development of revolutionary antiviral reusable facemasks.
“Israel has technologies that can support controlling this epidemic,” says Liat Goldhammer-Steinberg, CTO of Sonovia in Ramat Gan.
